darunavir has been researched along with ascorbic acid in 3 studies
| Studies (darunavir) | Trials (darunavir) | Recent Studies (post-2010) (darunavir) | Studies (ascorbic acid) | Trials (ascorbic acid) | Recent Studies (post-2010) (ascorbic acid) |
|---|---|---|---|---|---|
| 1,148 | 224 | 780 | 45,261 | 2,497 | 11,176 |
| Protein | Taxonomy | darunavir (IC50) | ascorbic acid (IC50) |
|---|---|---|---|
| Chain A, Hyaluronidase, phage associated | Streptococcus pyogenes | 1000 | |
| Urease | Canavalia ensiformis (jack bean) | 8.59 | |
| Solute carrier family 23 member 1 | Homo sapiens (human) | 156 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bellistrì, GM; Cannizzo, ES; d'Arminio Monforte, A; Garau, M; Mancusi, D; Marchetti, G; Savoldi, A; Termini, R; Tincati, C | 1 |
| Paital, B; Panda, M; Sahoo, A; Swain, SS | 1 |
1 review(s) available for darunavir and ascorbic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for darunavir and ascorbic acid
| Article | Year |
|---|---|
T-cell phenotype and function following a first cART regimen containing either a protease inhibitor or a non-nucleoside reverse transcriptase inhibitor in HIV-infected late presenters: results from a retrospective, ex vivo study.
Topics: Adult; Anti-HIV Agents; Ascorbic Acid; Darunavir; Drug Combinations; Female; HIV Infections; HIV Protease Inhibitors; Humans; Immunophenotyping; Male; Middle Aged; Niacin; Pyridoxine; Retrospective Studies; Reverse Transcriptase Inhibitors; Ritonavir; T-Lymphocytes; Zinc Compounds | 2016 |
Combinatorial approach of vitamin C derivative and anti-HIV drug-darunavir against SARS-CoV-2.
Topics: Anti-HIV Agents; Ascorbic Acid; COVID-19 Drug Treatment; Darunavir; Humans; Molecular Docking Simulation; SARS-CoV-2 | 2022 |